Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabolic and Signaling Pathways refers to the comprehensive set of chemical reactions and communication networks that maintain cellular life and coordinate responses to environmental cues. Metabolism involves the conversion of nutrients into energy and building blocks, while signaling pathways transmit information from the cell surface to the nucleus to regulate gene expression and cellular behavior (KEGG: Kyoto Encyclopedia of Genes and Genomes, 2023). This term is a functional category rather than a specific therapeutic target; it encompasses thousands of distinct proteins, including enzymes, receptors, and transcription factors. In clinical pharmacology, drugs are designed to modulate specific nodes within these pathways—such as the PI3K/AKT/mTOR signaling pathway or the glycolysis metabolic pathway—rather than the entire system at once (Nature Reviews Drug Discovery, 2021). Because it lacks a single molecular identity or a discrete binding site, it is classified as an incorrect target designation for drug development purposes.
Not applicable as this is a broad category of biological processes rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabolic and Signaling Pathways.